SUGAMMADEX NORMON 100 MG/ML SOLUCION INYECTABLE EFG Hispania - Kihispania - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

sugammadex normon 100 mg/ml solucion inyectable efg

laboratorios normon s.a. - sugammadex sodio - soluciÓn inyectable - 100 mg/ml inyectable 5 ml - sugammadex sodio 100 mg - sugammadex

SUGAMMADEX GLENMARK 100 MG/ML SOLUCION INYECTABLE EFG Hispania - Kihispania - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

sugammadex glenmark 100 mg/ml solucion inyectable efg

glenmark arzneimittel gmbh - sugammadex sodio - soluciÓn inyectable - 100 mg/ml inyectable 5 ml - sugammadex sodio 100 mg - sugammadex

SUGAMMADEX TARBIS 100 MG/ML SOLUCION INYECTABLE EFG Hispania - Kihispania - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

sugammadex tarbis 100 mg/ml solucion inyectable efg

tarbis farma s.l. - sugammadex sodio - soluciÓn inyectable - 100 mg/ml inyectable 5 ml - sugammadex sodio 100 mg - sugammadex

SUGAMMADEX BAXTER 100 MG/ML SOLUCION INYECTABLE EFG Hispania - Kihispania - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

sugammadex baxter 100 mg/ml solucion inyectable efg

baxter holding b.v. - sugammadex - soluciÓn inyectable - 100 mg/ml inyectable 5 ml - sugammadex 100 mg - sugammadex

Sugammadex Mylan Umoja wa Ulaya - Kislovakia - EMA (European Medicines Agency)

sugammadex mylan

mylan ireland limited - sugammadex sodium - neuromuskulárna blokáda - všetky ostatné terapeutické produkty - reversal of neuromuscular blockade induced by   rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Sugammadex Piramal Umoja wa Ulaya - Kifinlandi - EMA (European Medicines Agency)

sugammadex piramal

piramal critical care b.v. - sugammadex sodium - neuromuskulaarinen estäminen - sugammadeksi - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.

Sugammadex Adroiq Umoja wa Ulaya - Kiromania - EMA (European Medicines Agency)

sugammadex adroiq

extrovis eu ltd. - sugammadex sodium - blocaj blocant - toate celelalte produse terapeutice - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Sugammadex Fresenius Kabi Umoja wa Ulaya - Kidenmaki - EMA (European Medicines Agency)

sugammadex fresenius kabi

fresenius kabi deutschland gmbh - sugammadex sodium - neuromuskulær blokade - alle andre terapeutiske produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Sugammadex Adroiq Umoja wa Ulaya - Kidenmaki - EMA (European Medicines Agency)

sugammadex adroiq

extrovis eu ltd. - sugammadex sodium - neuromuskulær blokade - alle andre terapeutiske produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Sugammadex Adroiq Umoja wa Ulaya - Kiswidi - EMA (European Medicines Agency)

sugammadex adroiq

extrovis eu ltd. - sugammadex sodium - neuromuskulär blockade - alla andra terapeutiska produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.